Nuevolution AB (publ) announces timing for the release and webcast of the full year and fourth quarter 2018 interim results
Stockholm, 21 February 2019 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its interim report for the full year and fourth quarter 2018 on Thursday, 28 February after 18:00 CET.
On Friday, 1 March at 14:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows:
LIVE access on Friday 1 March at 14:00 CET
SE: +46 85 664 2705
DK: +45 7815 0110
UK: +44 33 3300 9034
US: +1 833 5268 380
For more information, please contact:
Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902
Johnny Stilou, CFO
Phone: +45 8877 5973
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.
The information was sent for publication, through the agency of the contact persons set out above, on Thursday 21 February 2019, 18:00 CET.
Nuevolution AB (publ) is listed at Nasdaq in Stockholm, Sweden (ticker: NUE). More information about Nuevolution can be found on: www.nuevolution.com